|
Life Sciences BPO – Service Provider Profile Compendium 2017
3 Nov 2017
by
Ankur Verma, Arushi Diwan, Manu Aggarwal, Naman Sharma
The life sciences BPO service provider profile compendium provides accurate, comprehensive, and fact-based profile snapshots of 13 service providers in the market. Specifically, the report allows for comparison of the service providers on their areas of strength and development. It helps current and potential buyers of life sciences BPO services to assess the service providers on the capabilities that they desire.
Each five-page profile presents a comprehensive picture of a provider’s service suite, scale of operations, technology solutions, and delivery locations; along with Everest Group’s assessment of the provider. The compendium also sheds light on the global life sciences BPO service provider landscape. These 13 service providers include Accenture, Cognizant, Conduent, DXC Technology, Genpact, HCL, IBM, Indegene, Syntel, TCS, Tech Mahindra, Wipro, and WNS.
Content
Each service provider profile captures the following life sciences BPO-specific details:
- Service suite and scale of operations: key leaders, service suite, FTEs, revenue, and recent developments
- Delivery locations: city-level detail of key delivery locations across the world
- Capabilities and clients: major engagements, revenue split by geography, FTE split by process coverage & location, and number of contracts by buyer size
- Technology solutions: brief profiles of key technology solutions
- Everest Group assessment: the position of the service provider on the Everest Group PEAK Matrix™, market share & delivery capability assessment, and overall remarks on the capabilities of the service provider
Membership(s)
Healthcare & Life Sciences Business Process Outsourcing
Page Count: 88
|
Other Users Also Viewed
29 Jun 2017
Globally, life sciences corporations are facing the dual danger of rising competition from generics as well as declining margins. Additionally, strengthening of regulations in every aspect of the life sciences value chain – drug discovery, trials,…
|